USE OF NANOTECHNOLOGICAL CONCEPTS AND TERMINOLOGY IN MEDICINE: CURRENT APPLICATIONS, CLINICAL VALUE, AND TRANSLATIONAL CHALLENGES

Abstract

Nanotechnology has become an important component of modern medicine because it provides new opportunities for targeted drug delivery, improved diagnostics, controlled release systems, and personalized treatment strategies. In medical literature, terms such as nanoparticles, liposomes, lipid nanoparticles, quantum dots, polymeric nanocarriers, and theranostic platforms are widely used to describe nanoscale systems designed for biomedical applications. These concepts are especially relevant in oncology, vaccine development, RNA-based therapeutics, molecular imaging, and biosensing.  The present article examines the use of nanotechnological terminology in medicine and discusses its clinical significance through an IMRAD-structured review. The analysis shows that nanotechnology improves the solubility, stability, bioavailability, and targeting efficiency of therapeutic agents while also enhancing diagnostic sensitivity. At the same time, the review highlights important translational challenges, including biocompatibility, protein corona formation, manufacturing reproducibility, and regulatory standardization, which influence the safe and effective implementation of nanomedicine in clinical practice.  Overall, nanotechnological terminology in medicine reflects not only a scientific vocabulary but also an evolving clinical paradigm that connects material science with patient-centered healthcare. The future of nanomedicine depends on the successful integration of innovative nanosystems into clinically practical, safe, and evidence-based medical solutions.